Amgen: The Giant With An Impressive Pipeline

JHVEPhoto "Science Lessons" is a famous book by Gordon Binder, the now 89 year-old who led Amgen (NASDAQ:AMGN) as CEO from 1988-2000 and CFO from 1982-1988. It discusses Amgen's growth as a biopharmaceutical company, along with the company's core focuses on discovery and science in what is an incredibly tough industry. As we'll see throughout this article, despite Amgen's recent stock price stagnation, the company has one of the best portfolios in the industry, making it a valuable investment. Amgen Horizon ...